rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Todd Wider

Director

Company insider

Files Form 4 as: Director, ASP Isotopes; Director, ARYA Sciences Acquisition Corp IV; Director, Abeona Therapeutics; Director, Arya Sciences Acquisition.

In numbers

Trades disclosed
71
Buys
3
Sells
11
Bought
$228K
Sold
$3.4M
Companies
4
Companies where not an officer
4
First trade
11 May 2015
Last trade
30 Jun 2026
Last filed
1 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ASPI ASP IsotopesDirector · Chemicals · last 30 Jun 20261 buy · 3 sells
ARYA Sciences Acquisition Corp IVDirector · last 31 Jul 20240 buys · 0 sells
ABEO Abeona TherapeuticsDirector · Biotechnology · last 26 Sep 20222 buys · 8 sells
Arya Sciences AcquisitionDirector · last 1 Jul 20200 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 1 Jul 2026ASPI ASP IsotopesChemicalsSEC FORM 4 Sold$306K50,000 at $6.12filing
30 Jun 2026filed 1 Jul 2026ASPI ASP IsotopesChemicalsSEC FORM 4 Sold$306K50,000 at $6.12filing
29 Jun 2026filed 1 Jul 2026ASPI ASP IsotopesChemicalsSEC FORM 4 Sold$313K50,000 at $6.25filing
29 Jun 2026filed 1 Jul 2026ASPI ASP IsotopesChemicalsSEC FORM 4 Sold$313K50,000 at $6.25filing
18 Dec 2025filed 22 Dec 2025ASPI ASP IsotopesChemicalsSEC FORM 4 Code A—36,548filing
12 Nov 2025filed 14 Nov 2025ASPI ASP IsotopesChemicalsSEC FORM 4 Code A—25,469filing
15 Sep 2025filed 3 Oct 2025ASPI ASP IsotopesChemicalsSEC FORM 4 Sold$649K74,108 at $8.76filing
14 Sep 2025filed 3 Oct 2025ASPI ASP Isotopesoption or derivative · ChemicalsSEC FORM 4 Code M—96,000 at $0.00filing
14 Sep 2025filed 3 Oct 2025ASPI ASP IsotopesChemicalsSEC FORM 4 Code M$192K96,000 at $2.00filing
14 Sep 2025filed 3 Oct 2025ASPI ASP IsotopesChemicalsSEC FORM 4 Code F$192K21,892 at $8.77filing
20 Nov 2024filed 21 Nov 2024ASPI ASP IsotopesChemicalsSEC FORM 4 Code A—42,522filing
13 Aug 2024filed 14 Aug 2024ASPI ASP IsotopesChemicalsSEC FORM 4 Code A—77,626filing
13 Aug 2024filed 14 Aug 2024ASPI ASP IsotopesChemicalsSEC FORM 4 Code A—95,238filing
31 Jul 2024filed 31 Jul 2024ARYA Sciences Acquisition Corp IVoption or derivativeSEC FORM 4 Code D—30,000filing
26 Oct 2023filed 30 Oct 2023ASPI ASP IsotopesChemicalsSEC FORM 4 Bought$91K94,844 at $0.96filing
15 Nov 2022filed 16 Nov 2022ASPI ASP IsotopesChemicalsSEC FORM 4 Code A—200,000 at $0.00filing
26 Sep 2022filed 28 Sep 2022ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—13,400 at $0.00filing
7 Oct 2021filed 8 Oct 2021ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Sold$24K25,000 at $0.97filing
25 May 2021filed 27 May 2021ABEO Abeona TherapeuticsBiotechnologySEC FORM 4 Code A—38,590 at $0.00filing
25 May 2021filed 27 May 2021ABEO Abeona Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—49,084 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care10
Materials4

Buys in green, sells in red, by the company’s sector.

Related people

Heather KiesslingChief Financial Officer · Chief Financial Officer at ASP Isotopes, filing Form 4 there in the last year
Robert AinscowCOO · COO at ASP Isotopes, filing Form 4 there in the last year
Robert John Andrew RyanDirector · Director at ASP Isotopes, filing Form 4 there in the last year
Donald George AinscowEVP, Gen Counsel, Secretary · EVP, Gen Counsel, Secretary at ASP Isotopes, filing Form 4 there in the last year
Paul Elliot MannChairman and CEO · Chairman and CEO at ASP Isotopes, filing Form 4 there in the last year
Brendan M. O'MalleySVP, Chief Legal Officer · Also traded ABEO in the last 90 days
Joseph Walter VazzanoChief Financial Officer · Also traded ABEO in the last 90 days
Madhav VasanthavadaChief Commercial Officer · Also traded ABEO in the last 90 days